Tsingke Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tsingke Biotechnology Co., Ltd. - overview
Established
2017
Location
Beijing, -, China
Primary Industry
Biotechnology
About
Based in Beijing, China, and established in 2017, Tsingke Biotechnology Co. , Ltd. is a biotechnology company that focuses on R&D of synthetic genomics and biosynthetic products. The company has clean production workshops, automated production equipment, and R&D center covering 12,000 square meters.
Moreover, it passed the CNAS quality system certification, and national high-tech enterprise certification. As of September 2021, Tsingke Biotechnology Co. , Ltd. has 1,700 employees.
Besides, the company has 122 patents, including 53 invention patents. Also, the company's businesses covered China, US, and German, and served for 120,000 clients. In January 2026, Tsingke Biotechnology Co. , Ltd.
closed a venture funding from New Third Board (NEEQ), under ticker "874813". The company's products and services can be divided into three categories, including synthetic genomics products and services, life science R&D equipment and raw materials, and contract development and manufacturing organization (CDMO) and contract research organization (CRO). For synthetic genomics field, the company completed about 200 million base syntheses, and manufactured 200 of nucleic acid raw materials and consumables every year. The company self-developed 768-channel blow-pressure synthetic equipment, and synthetic genomics production line that enables 160kb gene synthesis.
Current Investors
SB China Venture Capital, Sharewin Investment, In Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare, Medical Devices & Equipment, Pharmaceuticals, Medicinal Chemicals & Botanicals, Biomaterials
Website
www.tsingke.net
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.